Popular Categories
Dynavax Announces FDA Approval of HEPLISAV-B™ for Prevention of Hepatitis B in Adults
Dynavax Technologies Corporation announced that the U.S. Food & Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis B...
Nov 10, 2017 | Kim Rodgers
Hep C RNA Reflex Testing Health Code Amendment Adopted In NYC
The below information was originally published in a media advisory from Hep Free NYC. The NYC Board of Health Amended the Health Code...
Nov 07, 2017 | Kim Rodgers
Watch Now: Hepatitis A 2017 Outbreak Response – Lessons from Big Cities
On Friday, November 3, NACCHO hosted a webinar to highlight lessons learned and updates from jurisdictions experiencing outbreaks of...
Nov 07, 2017 | Kim Rodgers
CDC Report: Progress Toward Viral Hepatitis Elimination in the United States
The Centers for Disease Control and Prevention (CDC) recently released Progress Toward Viral Hepatitis Elimination in the United...
Nov 06, 2017 | Kim Rodgers
Success Stories: Unite to End the HIV and Viral Hepatitis Epidemics
As part of this year’s Unite to End the HIV and Viral Hepatitis Epidemics Chair’s Challenge, the National Alliance of State and...
Nov 03, 2017 | Kim Rodgers
Harvard’s Center for Health Law and Policy Innovation and National Viral Hepatitis...
Today, the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable...
Oct 25, 2017 | Andrea Grenadier
Join Now! New HHS Hepatitis C Medicaid Affinity Group
The Office of HIV/AIDS and Infectious Disease Policy (OHAIDP), in collaboration with the Centers for Medicare and Medicaid Services...
Oct 11, 2017 | Kim Rodgers
Call for Papers: Monitoring Disparities in Prevention and Treatment of HIV, Viral...
The American Journal of Public Health (AJPH) and the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS,...
Oct 05, 2017 | Kim Rodgers
HHS Blog: When it Comes to Curing Hepatitis C, Your Health Care Provider May Not...
This blog, written by Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health...
Sep 28, 2017 | Kim Rodgers
Dynavax Announces FDA Approval of HEPLISAV-B™ for Prevention of Hepatitis B in AdultsDynavax Technologies Corporation announced that the U.S. Food & Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is the first new hepatitis B vaccine in the United States in more than […] Nov 10, 2017 | Kim Rodgers |
Hep C RNA Reflex Testing Health Code Amendment Adopted In NYCThe below information was originally published in a media advisory from Hep Free NYC. The NYC Board of Health Amended the Health Code to Improve Complete Hepatitis C Diagnostic Testing in NYC In order to improve complete hepatitis C diagnostic testing, care and treatment rates in New York City at the population level, the Board […] Nov 07, 2017 | Kim Rodgers |
Watch Now: Hepatitis A 2017 Outbreak Response – Lessons from Big CitiesOn Friday, November 3, NACCHO hosted a webinar to highlight lessons learned and updates from jurisdictions experiencing outbreaks of hepatitis A virus. Since November 2016, in California alone, more than 600 people have been infected with hepatitis A, 395 people have been hospitalized, and 19 have died in outbreaks related to inadequate sanitation and hygiene. […] Nov 07, 2017 | Kim Rodgers |
CDC Report: Progress Toward Viral Hepatitis Elimination in the United StatesThe Centers for Disease Control and Prevention (CDC) recently released Progress Toward Viral Hepatitis Elimination in the United States, an inaugural report highlighting the nation’s progress toward reducing the burden of hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections. The report provides information on progress in the implementation of recommended... Nov 06, 2017 | Kim Rodgers |
Success Stories: Unite to End the HIV and Viral Hepatitis EpidemicsAs part of this year’s Unite to End the HIV and Viral Hepatitis Epidemics Chair’s Challenge, the National Alliance of State and Territorial AIDS Directors (NASTAD) released the second installment in a series of success stories collected from around the nation. This installment features programs from Michigan, North Carolina, and Philadelphia and highlights their health […] Nov 03, 2017 | Kim Rodgers |
Harvard’s Center for Health Law and Policy Innovation and National Viral Hepatitis Roundtable Launch Hepatitis C: State of Medicaid Access ReportToday, the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) launched the Hepatitis C: State of Medicaid Access report and state report cards. The report details hepatitis C treatment access restrictions in Medicaid programs in all states, the District of Columbia and Puerto Rico, […] Oct 25, 2017 | Andrea Grenadier |
Join Now! New HHS Hepatitis C Medicaid Affinity GroupThe Office of HIV/AIDS and Infectious Disease Policy (OHAIDP), in collaboration with the Centers for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), the Health Resources and Services Administration (HRSA), and the HHS Office of Minority Health (OMH), has launched a new joint initiative: the Hepatitis C Medicaid Affinity Group. […] Oct 11, 2017 | Kim Rodgers |
Call for Papers: Monitoring Disparities in Prevention and Treatment of HIV, Viral Hepatitis, STDs, and TBThe American Journal of Public Health (AJPH) and the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), plan to publish a theme issue on applying methods, metrics, and indicators for measuring disparities in health outcomes and risk behaviors for the prevention and treatment of HIV, […] Oct 05, 2017 | Kim Rodgers |
HHS Blog: When it Comes to Curing Hepatitis C, Your Health Care Provider May Not Need to Be A SpecialistThis blog, written by Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services, was originally published on the Department of Health and Human Services’ Viral Hepatitis Blog. Below is a brief snippet. Summary: Study published in Annals of Internal Medicine found no differences in sustained virologic response among... Sep 28, 2017 | Kim Rodgers |
Subscribe Today
Sign Up for the E-mail Digests
Create an account or login to MyNACCHO and go to "My Subscriptions."
SUBSCRIBE NOW
